| scholarly article | Q13442814 |
| P2093 | author name string | N Khandelwal | |
| Anil Bhansali | |||
| Vivek Gupta | |||
| Sanjay Bhadada | |||
| Vimal Upreti | |||
| Pinaki Dutta | |||
| Rama Walia | |||
| Naresh Sachdeva | |||
| Karan Saluja | |||
| R R Sharma | |||
| Sambit Das | |||
| N Marwaha | |||
| Ranjana Minz | |||
| Santosh Ramakrishnan | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 1407-1416 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Stem Cells and Development | Q15724421 |
| P1476 | title | Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | |
| P478 | volume | 18 |
| Q33746422 | A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. |
| Q95360893 | A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus |
| Q90479839 | Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications |
| Q24609292 | Adverse effect of high glucose concentration on stem cell therapy |
| Q35973271 | Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study |
| Q90236280 | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| Q38201302 | An update of human mesenchymal stem cell biology and their clinical uses. |
| Q55497165 | Analysis of the regulation pathways via microarray and miRNA studies: human embryonic stem cells to treat diabetes mellitus type-II. |
| Q92910500 | Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes |
| Q94410005 | Authors' response |
| Q38656266 | Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods |
| Q40967128 | Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity |
| Q90337073 | BMSCs and miR-124a ameliorated diabetic nephropathy via inhibiting notch signalling pathway |
| Q59594037 | Bone Marrow Stem Cells in Clinical Application: Harnessing Paracrine Roles and Niche Mechanisms |
| Q37780807 | Bone marrow and pancreatic islets: an old story with new perspectives |
| Q35778610 | Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy |
| Q33742259 | Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes |
| Q26748676 | Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis |
| Q43046013 | Effect of mesenchymal stem cells transplantation on glycaemic profile & their localization in streptozotocin induced diabetic Wistar rats |
| Q58634190 | Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study |
| Q34319707 | Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study |
| Q64282542 | Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation Therapy for Type 2 Diabetes Mellitus: An Updated Meta-Analysis |
| Q59337043 | Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models |
| Q34448821 | Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy |
| Q42915227 | Is the improved function of streptozotocin treated pancreas truly due to transdifferentiation/fusion of transplanted MSCs? |
| Q26864580 | Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus |
| Q38782963 | Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus |
| Q38114073 | Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges |
| Q33691629 | Mesenchymal stem cell therapy in type 2 diabetes mellitus |
| Q34158605 | Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy |
| Q92521567 | Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation |
| Q35976665 | Mesenchymal stem cells for the treatment of diabetes |
| Q35552255 | Metabolic and pancreatic effects of bone marrow mesenchymal stem cells transplantation in mice fed high-fat diet. |
| Q35842743 | Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients |
| Q82646631 | Regeneration of insulin production by autologous bone marrow blood autotransplantation in patients with type 1 diabetes |
| Q92219339 | Stem Cells from Human Exfoliated Deciduous Teeth Ameliorate Diabetic Nephropathy In Vivo and In Vitro by Inhibiting Advanced Glycation End Product-Activated Epithelial-Mesenchymal Transition |
| Q27011453 | Stem cell therapy for diabetes mellitus |
| Q64948643 | Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. |
| Q64086981 | Stem cells from human exfoliated deciduous teeth ameliorate type II diabetic mellitus in Goto-Kakizaki rats |
| Q26744774 | Stem cells to replace or regenerate the diabetic pancreas: Huge potential & existing hurdles |
| Q89496687 | The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis |
| Q92128776 | The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity |
| Q38181982 | The potential of cell-based therapy for diabetes and diabetes-related vascular complications |
| Q37121175 | Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus |
| Q36737833 | Therapeutic potential of mesenchymal stem cells in regenerative medicine |
| Q33725251 | Transfusion medicine in India: Expanding horizons |
| Q38048961 | Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine |
| Q36600189 | Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice |
| Q40321403 | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study |
Search more.